ICU Medical Inc
SWB:IC7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
ICU Medical Inc (IC7) under the Base Case is 154.87 EUR per share.
Compared with the current market price of 159 EUR, the stock appears
Overvalued by 3% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What ICU Medical Does
ICU Medical makes medical devices that hospitals use to move fluids into and out of patients safely. Its products include IV infusion pumps, administration sets, connectors, syringes, and other single-use items used in infusion therapy, vascular access, and blood collection. The company also serves critical-care areas where accurate fluid delivery and infection control matter.
- Headquarters
- United States of America US
- Employees
- 13 000
- IPO date
- Mar 31, 1992
ICU Medical has no economic moat
Several established medical-device companies sell competing infusion pumps, IV consumables and critical-care products, giving hospitals alternatives across much of ICU Medical’s range. Its products do not become more useful just because more hospitals use them, and its patents do not broadly keep rivals from offering competing products, so buyers can compare suppliers on price and product performance.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
Q3 growth and record sales in core businesses came alongside logistics-related mix disruption; management expects full-year adjusted earnings toward prior ranges’ high end and lowered planned capital spending.
What management delivered: 1 within the range
Open the earnings call- EPS
- $2.11
- Expected
- $1.75
- Surprise
- +20.6%
- Stock, next trading day
- +2.7%
ICU Medical insiders are selling less than usual
Past 12 months
Continue IC7 Research
Decided on ICU Medical? Get an email when IC7 reaches the price you’d buy at. Free with an account.
Other ICU Medical listings
What is the Intrinsic Value of one IC7 stock?
The intrinsic value for
ICU Medical Inc (IC7) under the Base Case is 154.87 EUR.
Is IC7 stock undervalued or overvalued?
Compared with the current market price of 159 EUR, the stock appears Overvalued by 3% .